Literature DB >> 3167776

Menstrual factors and breast cancer risk.

G Kvåle1, I Heuch.   

Abstract

Relationships between menstrual factors and breast cancer risk were investigated in a prospective study of 63,090 Norwegian women. A total of 1565 cases of breast cancer occurred during follow-up from 1961 through 1980. The risk of breast cancer decreased with increasing age at menarche (P = 0.06) and increased with increasing age at menopause (P = 0.005) in analyses adjusted for age, urban/rural place of residence, parity, and age at first and last birth. The results correspond to an average increase in breast cancer risk of 4.0% for each year of decrease in age at menarche, and an increase in risk of 3.6% for each year of increase in age at menopause. The protective effect of early menopause was strongest for breast cancer diagnosed in patients 80 years of age or older. No clear relationship was seen between menstrual irregularities and breast cancer risk.

Entities:  

Mesh:

Year:  1988        PMID: 3167776     DOI: 10.1002/1097-0142(19881015)62:8<1625::aid-cncr2820620828>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  A case-control study of menstrual factors in relation to breast cancer risk in African-American women.

Authors:  Jessica S B Beiler; Kangmin Zhu; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Vernon M Chinchilli
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

2.  Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk.

Authors:  Hazel B Nichols; Donna D Baird; Frank Z Stanczyk; Anne Z Steiner; Melissa A Troester; Kristina W Whitworth; Dale P Sandler
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

3.  Birth season and breast cancer risk in Japan.

Authors:  Y H Hu; T Kuroishi; Y Matsushita; C Nagata; H Shimizu
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Impact of menstrual and reproductive factors on breast cancer risk in Tunisia: a case-control study.

Authors:  Awatef Msolly; Olfa Gharbi; Slim Ben Ahmed
Journal:  Med Oncol       Date:  2013-02-02       Impact factor: 3.064

5.  Lifetime menstrual activity--indicator of breast cancer risk.

Authors:  M Rautalahti; D Albanes; J Virtamo; J Palmgren; J Haukka; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

6.  Growth in precocious puberty.

Authors:  Justin J Brown; Garry L Warne
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

7.  Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.

Authors:  E L Milliken; K L Lozada; E Johnson; M D Landis; D D Seachrist; I Whitten; A L M Sutton; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

Review 8.  Progesterone receptor isoform functions in normal breast development and breast cancer.

Authors:  Anastasia Kariagina; Mark D Aupperlee; Sandra Z Haslam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

9.  Birth characteristics and age at menarche: results from the dietary intervention study in children (DISC).

Authors:  Elizabeth H Ruder; Terryl J Hartman; Michael J Rovine; Joanne F Dorgan
Journal:  Cancer Causes Control       Date:  2010-05-22       Impact factor: 2.506

10.  Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk.

Authors:  Joanne F Dorgan; Frank Z Stanczyk; Brian L Egleston; Lisa L Kahle; Christiana M Shaw; Cynthia S Spittle; Andrew K Godwin; Louise A Brinton
Journal:  J Natl Cancer Inst       Date:  2009-10-09       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.